tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Developments and Strategic Expansion Bolster Trevi Therapeutics’ Growth Potential
PremiumRatingsPromising Developments and Strategic Expansion Bolster Trevi Therapeutics’ Growth Potential
2M ago
Trevi Therapeutics price target lowered to $27 from $29 at Raymond James
Premium
The Fly
Trevi Therapeutics price target lowered to $27 from $29 at Raymond James
2M ago
Promising Phase 2b Results and Strong Financial Position Drive Buy Rating for Trevi Therapeutics
Premium
Ratings
Promising Phase 2b Results and Strong Financial Position Drive Buy Rating for Trevi Therapeutics
2M ago
Trevi Therapeutics Stockholders Approve Key Amendments
PremiumCompany AnnouncementsTrevi Therapeutics Stockholders Approve Key Amendments
3M ago
Trevi Therapeutics: Positive Developments and Financial Strength Support Buy Rating
Premium
Ratings
Trevi Therapeutics: Positive Developments and Financial Strength Support Buy Rating
4M ago
Trevi Therapeutics Announces Public Offering Pricing
Premium
Company Announcements
Trevi Therapeutics Announces Public Offering Pricing
4M ago
Trevi Therapeutics Terminates ATM Prospectus with Leerink
PremiumCompany AnnouncementsTrevi Therapeutics Terminates ATM Prospectus with Leerink
4M ago
Trevi Therapeutics price target raised to $23 from $20 at Oppenheimer
Premium
The Fly
Trevi Therapeutics price target raised to $23 from $20 at Oppenheimer
4M ago
Trevi Therapeutics announces $100M common stock offering
Premium
The Fly
Trevi Therapeutics announces $100M common stock offering
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100